Author
@fwpharma fwpharma
Biopharma trade-press feed relaying FDA, clinical, M&A and earnings news in real time
FirstWord Pharma's account broadcasts comprehensive, first-p
trader score
+0.98
hit rate
65%
mean α
+0.41%
signals 14d
65
Grade = how their written analysis reads (A best). Trader score = how their last-20 timestamped calls performed vs SPY.
Their picks, scored
Across their last 20 scored bets: 65% hit rate, +0.41% mean alpha, trader score +0.98. Their last-14d mentions, direction-adjusted, have moved -1.6% since posting (mean over 31 mentions with price data).
Recent signals15receipts included
| date (PT) | ticker | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|---|
| 2026-08-28 | BNTX | @fwpharma | -0.45 | BioNTech ends a colorectal study of its mRNA vaccine. | — | tweet ↗ |
| 2026-08-28 | TEVA | @fwpharma | -0.10 | Teva bids up to 125M for BioXcel neuroscience assets in a bankruptcy sale. | — | tweet ↗ |
| 2026-08-28 | BTAI | @fwpharma | +0.50 | Teva bids up to 125M for BioXcel neuroscience assets in a bankruptcy sale. | · | tweet ↗ |
| 2026-08-28 | IONS | @fwpharma | -0.15 | Reports an AstraZeneca ATTR-CM study miss that raises questions for competing therapies. | · | tweet ↗ |
| 2026-08-28 | ALNY | @fwpharma | -0.15 | Reports an AstraZeneca ATTR-CM study miss that raises questions for competing therapies. | — | tweet ↗ |
| 2026-08-28 | AZN | @fwpharma | -0.45 | Reports an AstraZeneca ATTR-CM study miss that raises questions for competing therapies. | — | tweet ↗ |
| 2026-08-28 | RHHBY | @fwpharma | +0.25 | Roche signs an antibody-drug-conjugate deal with DualityBio worth more than 1B. | — | tweet ↗ |
| 2026-08-28 | CYTK | @fwpharma | +0.30 | Reports Cytokinetics is preparing an FDA filing for non-obstructive HCM. | — | tweet ↗ |
| 2026-08-27 | BMY | @fwpharma | +0.20 | Reports BMS committed another $173M to radiopharmaceutical manufacturing. | -0.6% | tweet ↗ |
| 2026-08-27 | GILD | @fwpharma | +0.50 | Reports FDA approval of Gilead's daily HIV treatment pill Bixlenvo. | -2.1% | tweet ↗ |
| 2026-08-27 | ROIV | @fwpharma | +0.50 | Priovant's inhibitor received FDA approval for dermatomyositis. | · | tweet ↗ |
| 2026-08-27 | · | @fwpharma | · | Gates committed $35 million to ProFound's preeclampsia proteomics work. | · | tweet ↗ |
| 2026-08-27 | MRNA | @fwpharma | -0.30 | Moderna is moving to raise $2 billion after a cancer-vaccine win. | -3.3% | tweet ↗ |
| 2026-08-27 | AMGN | @fwpharma | +0.40 | A pivotal Tezspire study win supports pursuit of a third indication in eosinophilic oesophagitis. | -1.0% | tweet ↗ |
| 2026-08-27 | AZN | @fwpharma | +0.40 | A pivotal Tezspire study win supports pursuit of a third indication in eosinophilic oesophagitis. | -1.1% | tweet ↗ |
Grade is our human read-worthiness rating; trader score is a rolling 20-bet hit-rate/alpha composite — different things, often disagreeing. “Since then” is direction-unaware in the table; the summary line above adjusts for which way they leaned.